+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Anti-tumour activity of all-trans retinoic acid alone and in combination with IFN alpha-2b and cisplatin in human testicular cancer cell lines



Anti-tumour activity of all-trans retinoic acid alone and in combination with IFN alpha-2b and cisplatin in human testicular cancer cell lines



Annals of Hematology 67(SUPPL ): A26




(PDF emailed within 1 workday: $29.90)

Accession: 030107437

Download citation: RISBibTeXText


Related references

Antiproliferative effects of interferon alpha-2a in combination with all trans retinoic acid or cisplatin in human ovarian carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 293, 1996

Antiproliferative effects of interferons -alpha and -beta in combination with 5-fluorouracil, cisplatin, and cis- and trans-retinoic acid in three human lung carcinoma cell lines. Journal of Interferon Research 13(1): 25-32, 1993

Antiproliferative effects of alpha and beta interferon in combination with 5 fluorouracil cisplatin and cis and trans retinoic acid in two non small cell lung carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 32: 228, 1991

Effect of all-trans retinoic acid on the growth of two nasopharyngeal cancer cell lines and its treatment potential in combination with cisplatin. European Archives of Oto-Rhino-Laryngology 270(2): 695-704, 2013

Cytotoxic effect of interferon-alpha2a in combination with all-trans retinoic acid or cisplatin in human ovarian carcinoma cell lines. Anti-Cancer Drugs 9(3): 229-238, 1998

All-trans retinoic acid enhances the activity of cisplatin in head-and-neck cancer and ovarian cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 287, 1995

Differential effects of all-trans retinoic acid and docosahexaenoic acid on cisplatin-induced cytotoxicity and apoptosis in cisplatin sensitive and resistant human embryonal carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 401, 1996

Responsiveness of human non-small cell lung cancer lines to combination therapy with all-trans retinoic acid and thalidomide. Proceedings of the American Association for Cancer Research Annual Meeting 43: 764, 2002

Enhancement of cisplatin cytotoxicity by all trans retinoic acid on human ovarian carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 293, 1995

Effect of all-trans retinoic acid on the apoptosis induced by cisplatin and Taxol in ovarian cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 23, 1996

P53-independent induction of p21-WAF1 and apoptosis by all-trans-retinoic acid and 9-cis-retinoic acid in human prostate cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 10, 1995

Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics. Anticancer Research 21(2b): 1431-1437, 2001

Modulation of cisplatin cytotoxicity by human recombinant interferon gamma and all trans-retinoic acid in four human ovarian cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 295, 1993

Induction of the apoptosis of human hepatocellular carcinoma SMMC-7721 cell strain with cisplatin in combination with all trans-retinoic acid. Scandinavian Journal of Gastroenterology 33(SUPPL 227): 30, 1998

Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines. British Journal of Cancer 75(3): 333-340, 1997